Here’s what you should know.
1. The U.S. tests its corn for Aspergillus and turns away over-contaminated produce, but internationally produce remains untested. Dr. Schmidt estimates some 4.5 billion people consume Aspergillus regularly.
2. This GMO shuts Aspergillus and prevents it from accumulating in corn.
3. Dr. Schmidt believes the GMO will make a difference in the U.S. and in the rest of the world.
4. People from undeveloped countries are 16 times to 32 times more likely to develop liver cancer after consuming Aspergillus.
5. Dr. Schmidt and researchers can silence aflatoxin genes in corn. The ear will still show powder spores on the surface, but the kernels remain uncontaminated.
6. Dr. Schmidt and colleagues are seeking funding to expand testing efforts. She predicts, in this regulatory environment, the corn could be available in 10 years to 20 years.
More articles on gastroenterology:
CMS announces new Crohn’s Disease code after AGA, ACG petition — 4 insights
IBS-D puts financial strain on patients: 4 study insights
Aries launches Eleview injectable for GI endoscopy: 4 key notes
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
